Publisher
Springer Berlin Heidelberg
Reference16 articles.
1. Fonatsch C, Gradl G (1988) Cytogenetic findings in myeloproliferative disorders. In: Huhn D, Hellriegel KP, Niederle N (eds) Chronic myelocytic leukemia and interferon: pathophysiological, clinical, and therapeutic aspects. Springer, Berlin Heidelberg New York, pp 1–18
2. Tartaglia ED, Goldberg JD, Berk PD, Wasserman LR (1986) Adverse effects of antiaggregating platelet therapy in the treatment of polycythaemia vera. Semin Hematol 23: 172–176
3. Niederle N, Moritz T, Kloke 0, Wandl U, May D, Becher R, Franz T, Opalka B, Schmidt CG (1991) Interferon alfa-2b in acute-and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients. Eur J Cancer 27 (Suppl 4) 7–14
4. Niederle N (1990) Zur Behandlung myeloproliferativer Syndrome mit Interferonen. In: Niederle N, von Wussow P (eds) Interferone: Präklinische und klinische Befunde. Springer, Berlin Heidelberg New York, 215–233
5. Bolin RW, Robinson WA, Sutherland J, Hamman RF (1982) Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. Cancer 50: 1683–1687